Huang-Ge Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huang-Ge Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Donald Miller
Brown Cancer Center, Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA
2 shared publicationsXiaoying Zhuang
Brown Cancer Center, Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA
2 shared publications- Abhilash Samykutty
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA
1 shared publication Cunren Liu
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
1 shared publicationD Miller
Department of Microbiology & Immunology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA
1 shared publicationDongmei Sun
Department of Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24 (1) , 96-105
Grapefruit-derived Nanovectors Delivering Therapeutic miR17 Through an Intranasal Route Inhibit Brain Tumor Progression
- 1 January 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24 (1) , 96-105
Open AccessGrapefruit-derived Nanovectors Delivering Therapeutic miR17 Through an Intranasal Route Inhibit Brain Tumor Progression
- Open Access
- 4 April 2011
- Published by Springer Nature in Oncogene
- Vol. 30 (31) , 3440-3453
miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT
A micro-RNA, miR-155, is overexpressed in many types of cancer cells, including breast cancer, and its role(s) in tumor metastasis has been studied on a very limited basis. Tumor metastasis is a multi-step process with the last step in the process being formation of macroscopic tumor in organs distant from the primary tumor site. This step is the least studied. Here, we report that stable expression of miR-155 in 4T1 breast tumor cells reduces significantly the aggressiveness of tumor cell dissemination as a result of preventing epithelial-to-mesenchymal transition (EMT) of tumor cells in vivo. Further, miR-155 directly suppresses the expression of the transcription factor TCF4, which is an important regulator of EMT. However, when tumor cells are injected directly into the bloodstream, miR-155 remarkably promotes macroscopic tumor formation in the lung. Analysis of gene expression profiling identified a group of genes that are associated with promoting macroscopic tumor formation in the lung. Importantly, most of these genes are overexpressed in epithelial cells. Our findings provide new insight into how miR-155 modulates the development of tumor metastasis. This study suggests that the location of tumor cells overexpressing miR-155 is a critical factor: in mammary fat pads miR-155 prevents tumor dissemination; whereas in the lung miR-155 apparently maintains the epithelial phenotype of tumor cells that is critical for macroscopic tumor formation.
- 4 April 2011
- Published by Springer Nature in Oncogene
- Vol. 30 (31) , 3440-3453
Open AccessmiR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT
A micro-RNA, miR-155, is overexpressed in many types of cancer cells, including breast cancer, and its role(s) in tumor metastasis has been studied on a very limited basis. Tumor metastasis is a multi-step process with the last step in the process being formation of macroscopic tumor in organs distant from the primary tumor site. This step is the least studied. Here, we report that stable expression of miR-155 in 4T1 breast tumor cells reduces significantly the aggressiveness of tumor cell dissemination as a result of preventing epithelial-to-mesenchymal transition (EMT) of tumor cells in vivo. Further, miR-155 directly suppresses the expression of the transcription factor TCF4, which is an important regulator of EMT. However, when tumor cells are injected directly into the bloodstream, miR-155 remarkably promotes macroscopic tumor formation in the lung. Analysis of gene expression profiling identified a group of genes that are associated with promoting macroscopic tumor formation in the lung. Importantly, most of these genes are overexpressed in epithelial cells. Our findings provide new insight into how miR-155 modulates the development of tumor metastasis. This study suggests that the location of tumor cells overexpressing miR-155 is a critical factor: in mammary fat pads miR-155 prevents tumor dissemination; whereas in the lung miR-155 apparently maintains the epithelial phenotype of tumor cells that is critical for macroscopic tumor formation.
- Top Cited PapersOpen Access
- 1 September 2010
- Published by Elsevier in Molecular Therapy
- Vol. 18 (9) , 1606-1614
A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
- 1 September 2010
- Published by Elsevier in Molecular Therapy
- Vol. 18 (9) , 1606-1614
Top Cited PapersOpen AccessA Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes